Transcatheter Amplatzer Device Closure of Atrial Septal Defect and Patent Foramen Ovale in Patients with Presumed Paradoxical Embolism

Mayo Clinic Proceedings

Volumn 79, Issue 1, 2004, Pages 35-41

  Khositseth, Anant ^a,c   Cabalka, Allison K ^a   Sweeney, John P ^b   Fortuin, F David ^b   Reeder, Guy S ^a   Connolly, Heidi M ^a   Hagler, Donald J ^a  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; WARFARIN;

ADULT; AGED; ANGIOGRAPHY; BLOOD VESSEL INJURY; COMPUTER ASSISTED TOMOGRAPHY; DEVICE INFECTION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM DEFECT; HEART LEFT RIGHT SHUNT; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARADOXICAL EMBOLISM; RECURRENT DISEASE; RETINA ARTERY OCCLUSION; REVIEW; SINUS NODE DYSFUNCTION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK;

EID: 0346362406     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/79.1.35     Document Type: Article

References (33)

1. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life an autopsy study of 965 normal hearts. Mayo Clin Proc 1984;59:17-20
2. Fisher DC, Fisher EA, Budd JH, Rosen SE, Goldman ME. The incidence of patent foramen ovale in 1,000 consecutive patients: a contrast transesophageal echocardiography study. Chest 1995;107:1504-1509.
3. Lynch JJ, Schuchard GH, Gross CM, Wann LS. Prevalence of right-to-left atrial shunting in a healthy population detection by Valsalva maneuver contrast echocardiography. Am J Cardiol 1984;53:1478-1480.
4. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000;55:1172-1179.
5. Berthet K, Lavergne T, Cohen A, et al. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke 2000;31:398-403.
6. Job FP, Ringelstein EB, Grafen Y, et al. Comparison of transcranial contrast Doppler sonography and transesophageal contrast echocardiography for the detection of patent foramen ovale in young stroke patients. Am J Cardiol. 1994;74:381-384.
7. Labovitz AJ, Camp A, Castello R, et al. Usefulness of transesophageal echocardiography in unexplained cerebral ischemia. Am J Cardiol 1993;72:1448-1452.
8. Nendaz MR, Sarasin FP, Junod AF, Bogousslavsky J. Preventing stroke recurrence in patients with patent foramen ovale: antithrombotic therapy, foramen closure, or therapeutic abstention? a decision analytic perspective. Am Heart J. 1998;135:532-541.
9. Nendaz M, Sarasin FP, Bogousslavsky J. How to prevent stroke recurrence in patients with patent foramen ovale, anticoagulants, antiaggregants, foramen closure, or nothing? Eur Neurol 1997;37:199-204.
10. Berdat PA, Chastterjee T, Pfammatter JP, Windecker S, Meier B, Carrel T. Surgical management of complications after trancatheter closure of an atrial septal defect or patent foramen ovale. J Thorac Cardiovasc Surg. 2000;120:1034-1039.
11. Brandt RR, Neumann T, Neuzner J, Rau M, Faude I, Hamm CW. Transcatheter closure of atrial septal defect and patent foramen ovale in adult patients using the Amplatzer occlusion device: no evidence for thrombus deposition with antiplatelet agents. J Am Soc Echocardiogr. 2002;15(10, pt 1):1094-1098.
12. Braun MU, Fassbender D, Schoen SP, et al. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol. 2002;39:2019-2025.
13. Onorato E, Pera IG, Melzi G, Rigatelli G. Persistent redundant Eustachian valve interfering with Amplatzer PFO occluder placement anatomico-clinical and technical implications. Catheter Cardiovasc Interv. 2002;55:521-524.
14. Martin F, Sanchez PL, Doherty E, et al. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation. 2002;106:1121-1126.
15. Bruch L, Parsi A, Grad MO, et al. Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism: single-center experience. Circulation. 2002;105:2845-2848.
16. Sievert H, Horvath K, Zadan E, et al. Patent foramen ovale closure in patients with transient ischemia attack/stroke. J Interv Cardiol. 2001;14:261-266.
17. Du ZD, Cao QL, Joseph A, et al. Transcatheter closure of patent foramen ovale in patients with paradoxical embolism: intermediate-term risk of recurrent neurological events. Catheter Cardiovasc Interv. 2002;55:189-194.
18. Sharafuddin MJ, Gu X, Titus JL, Urness M, Cervera-Ceballos JJ, Amplatz K. Transvenous closure of secundum atrial septal defects: preliminary results with a new self-expanding nitinol prosthesis in a swine model [published correction appears in Circulation. 1998; 97:413]. Circulation. 1997;95:2162-2168.
19. Sharafuddin MJ, Gu X, Titus JL, Urness M, Cervera-Ceballos JJ, Amplatz K. Transvenous closure of secundum atrial septal defects: preliminary results with a new self-expanding nitinol prosthesis in a swine model [published correction appears in Circulation. 1998; 97:413]. Circulation. 1997;95:2162-2168.
20. Walsh KP, Wilmshurst PT, Morrison WL. Transcatheter closure of patent foramen ovale using the Amplatzer septal occluder to prevent recurrence of neurological decompression illness in divers. Heart. 1999;81:257-261.
21. Walsh KP, Maadi IM. The Amplatzer septal occluder. Cardiol Young. 2000;10:493-501.
22. Windecker S, Meier B. Percutaneous patent foramen ovale (PFO) closure: it can be done but should it? [editorial]. Catheter Cardiovasc Interv. 1999;47:377-380.
23. Windecker S, Wahl A, Chatterjee T, et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation. 2000;101:893-898.
24. Bridges ND, Hellenbrand W, Latson L, Filiano J, Newburger JW, Lock JE. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation. 1992;86:1902-1908.
25. Sievert H, Babic UU, Hausdorf G, et al. Transcatheter closure of atrial septal defect and patent foramen ovale with ASDOS device (a multi-institutional European trial). Am J Cardiol. 1998;82:1405-1413.
26. Hung J, Landzberg MJ, Jenkins KJ, et al. Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol. 2000;35:1311-1316.
27. Comess KA, DeRook FA, Beach KW, Lytle NJ, Golby AJ, Albers GW. Transesophageal echocardiography and carotid ultrasound in patients with cerebral ischemia: prevalence of findings and recurrent stroke risk. J Am Coll Cardiol. 1994;23:1598-1603.
28. Mas JL, Zuber M, French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. Am Heart J. 1995;130:1083-1088.
29. Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer N, Van Melle G, Lausanne Stroke with Paradoxal Embolism Study Group. Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Neurology. 1996;46:1301-1305.
30. Mas JL, Arquizan C, Lamy C, et al, Patent Foramen Ovale and Atrial Septal Aneurysm Study Group. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001;345:1740-1746.
31. Dearani JA, Ugurlu BS, Danielson GK, et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation. 1999;100(19, suppl):II171-II175.
32. Homma S, Di Tullio MR, Sacco RL, Sciacca RR, Smith C, Mohr JP. Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke. 1997;28:2376-2381.
33. Ruchat P, Bogousslavsky J, Hurni M, Fischer AP, Jeanrenaud X, von Segesser LK. Systematic surgical closure of patent foramen ovale in selected patients with cerebrovascular events due to paradoxical embolism: early results of a preliminary study. Eur J Cardiothorac Surg. 1997;11:824-827.